1. A tidal volume of 7 mL/kg PBW or higher may be safe for COVID-19 patients
- Author
-
Protti, A, Madotto, F, Florio, G, Bove, T, Carlesso, E, Casella, G, Dalla Corte, F, Foti, G, Giudici, R, Langer, T, Montalto, C, Rezoagli, E, Santini, A, Terragni, P, Zanella, A, Grasselli, G, Cecconi, M, Protti A., Madotto F., Florio G., Bove T., Carlesso E., Casella G., Dalla Corte F., Foti G., Giudici R., Langer T., Montalto C., Rezoagli E., Santini A., Terragni P., Zanella A., Grasselli G., Cecconi M., Protti, A, Madotto, F, Florio, G, Bove, T, Carlesso, E, Casella, G, Dalla Corte, F, Foti, G, Giudici, R, Langer, T, Montalto, C, Rezoagli, E, Santini, A, Terragni, P, Zanella, A, Grasselli, G, Cecconi, M, Protti A., Madotto F., Florio G., Bove T., Carlesso E., Casella G., Dalla Corte F., Foti G., Giudici R., Langer T., Montalto C., Rezoagli E., Santini A., Terragni P., Zanella A., Grasselli G., and Cecconi M.
- Abstract
Purpose: The novel coronavirus disease (COVID-19) has revived the debate on the optimal tidal volume during acute respiratory distress syndrome (ARDS). Some experts recommend 6 mL/kg of predicted body weight (PBW) for all patients, while others suggest 7–9 mL/kg PBW for those with compliance >50 mL/cmH2O. We investigated whether a tidal volume ≥ 7 ml/kg PBW may be safe in COVID-19 patients, particularly those with compliance >50 mL/cmH2O. Materials and methods: This secondary analysis of a multicenter study compares the Intensive Care Unit (ICU) mortality among 600 patients ventilated with <7 or ≥ 7 mL/kg PBW. Compliance was categorized as <40, 40–50, or > 50 mL/cmH2O. Results: 346 patients were ventilated with <7 (6.2 ± 0.5) mL/kg PBW and 254 with ≥7 (7.9 ± 0.9) mL/kg PBW. ICU mortality was 33 % and 29 % in the two groups (p = 0.272). At multivariable regression analysis, tidal volume ≥ 7 mL/kg PBW was associated with lower ICU mortality in the overall population (odds ratio: 0.62 [95 %-confidence interval: 0.40–0.95]) and in each compliance category. Conclusions: A tidal volume ≥ 7 (up to 9) mL/kg PBW was associated with lower ICU mortality in these COVID-19 patients, including those with compliance <40 mL/cmH2O. This finding should be interpreted cautiously due to the retrospective study design. Trial registration: ClinicalTrails.gov NCT04388670.
- Published
- 2025